CGON
Cg Oncology Inc.

493
Mkt Cap
$4.41B
Volume
136,636.00
52W High
$57.40
52W Low
$14.80
PE Ratio
-27.58
CGON Fundamentals
Price
$54.68
Prev Close
$54.73
Open
$53.55
50D MA
$42.62
Beta
1.61
Avg. Volume
837,225.95
EPS (Annual)
-$1.16
P/B
6.23
Rev/Employee
$10,079.65
Loading...
Loading...
News
all
press releases
CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why
CGON expects phase III PIVOT-006 top-line data in first-half 2026, nearly a year early, after enrollment finished ahead of schedule across more than 90 sites.
Zacks·5d ago
News Placeholder
More News
News Placeholder
CG Oncology (NASDAQ:CGON) Shares Down 6.3% - Here's What Happened
CG Oncology (NASDAQ:CGON) Stock Price Down 6.3% - What's Next...
MarketBeat·15d ago
News Placeholder
Voya Investment Management LLC Has $1.93 Million Stock Holdings in CG Oncology, Inc. $CGON
Voya Investment Management LLC increased its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 217.6% during the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·22d ago
News Placeholder
CG Oncology, Inc. (NASDAQ:CGON) Given Average Rating of "Moderate Buy" by Brokerages
Shares of CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the fifteen analysts that are presently covering the firm...
MarketBeat·1mo ago
News Placeholder
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases Shares of 26,000 CG Oncology, Inc. $CGON
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) in the second quarter, according to its most recent 13F...
MarketBeat·1mo ago
News Placeholder
CG Oncology (NASDAQ:CGON) Earns Outperform Rating from Analysts at Wedbush
Wedbush started coverage on CG Oncology in a research report on Thursday. They set an "outperform" rating and a $70.00 price objective for the company...
MarketBeat·1mo ago
News Placeholder
CG Oncology (NASDAQ:CGON) Sets New 1-Year High - Still a Buy?
CG Oncology (NASDAQ:CGON) Hits New 12-Month High - Should You Buy...
MarketBeat·1mo ago
News Placeholder
Schroder Investment Management Group Acquires 155,737 Shares of CG Oncology, Inc. $CGON
Schroder Investment Management Group boosted its stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 143.8% in the second quarter, according to the company in its most recent Form 13F...
MarketBeat·2mo ago
News Placeholder
FY2025 EPS Estimates for CG Oncology Increased by Analyst
CG Oncology, Inc. (NASDAQ:CGON - Free Report) - Stock analysts at Lifesci Capital lifted their FY2025 earnings per share (EPS) estimates for shares of CG Oncology in a research report issued to...
MarketBeat·2mo ago
News Placeholder
CG Oncology, Inc. $CGON Shares Purchased by Franklin Resources Inc.
Franklin Resources Inc. grew its stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 12.7% in the second quarter, according to its most recent filing with the SEC. The fund owned...
MarketBeat·2mo ago
<
1
2
...
>

Latest CGON News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.